Menu
  • Join
  • Login
  • Contact
 

Search abstracts


MEDICATION PREFERENCES OF MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS) PATIENTS

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: ARAJA, Diana (Latvia)
  • Co-author(s): Diana Araja: Riga Stradins University, Riga, Latvia
    Elenka Brenna: Università Cattolica del Sacro Cuore, Rome, Italy
    Derek Pheby: Buckinghamshire New University, London, United Kingdom
    Uldis Berķis: Riga Stradins University, Riga, Latvia
    Asja Lunga: Riga Stradins University, Riga, Latvia
    Modra Murovska: Riga Stradins University, Riga, Latvia
  • Abstract:

    Background

    Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a multi-system disorder, which lead to substantial reductions in functional activity and quality of life. There are no Europe-wide prevalence data, but it is estimated that there are some two million sufferers in Europe as a whole.

    Methods

    To achieve the goal of this research,

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses